This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
EU Pharmaceutical Law Forum 2024
May 21-23, 2024Steigenberger Wiltcher's, Brussels

Ingrid Vandenborre
Partner, Antitrust/Competition at Skadden, Arps, Slate, Meagher & Flom
Speaker

Profile

Ingrid Vandenborre is the partner in charge of Skadden’s Brussels office and co-head of Skadden’s European Antitrust/Competition practice. Her practice focuses on EU and international merger control and competition law enforcement.

Ms. Vandenborre has been consistently named as a leading practitioner in Who’s Who Legal guides in both competition and life sciences, as well as repeatedly in Chambers Global, Chambers Europe and The Legal 500 EMEA. In 2023, she was named Antitrust & Competition Lawyer of the Year at the Women in Business Law EMEA Awards. Ms. Vandenborre also was named Lawyer of the Year by Global Competition Review in 2022, was selected to GCR’s Women in Antitrust list in 2021 and was recognized for her representation of Aspen Pharmacare in relation to the European Commission’s (EC) Article 102 investigation of the company’s pricing practices, which was named European Behavioural Matter of the Year by the publication. In addition, she was named a 2021 Competition MVP by Law360, a 2021 Litigation Star for Belgium - Competition/Antitrust by Benchmark Litigation Europe and Competition Lawyer of the Year at Benchmark Litigation Europe’s 2020 Awards, which also recognized her work advising Aspen as an Impact Case of the Year. She currently serves as nongovernmental adviser to the intergovernmental International Competition Network.

Ms. Vandenborre has significant experience in Article 101 and 102 issues in relation to cartel arrangements, as well as vertical and competitive agreements and alleged abuse of dominance. She also has a significant merger control practice, extending to the EC and the U.K. Competition and Markets Authority.

Agenda Sessions

  • PANEL Merger Control and Expanded Jurisdictional Reach Developments and Strategy

    09:45